On August 26, 2024 Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, reported that management will participate in the H.C. Wainwright 26th Annual Global Investment Conference being held September 9th – 11, 2024 at the Lotte New York Palace Hotel in New York City (Press release, Anixa Biosciences, AUG 26, 2024, https://ir.anixa.com/news/detail/1048/anixa-biosciences-to-present-at-the-h-c-wainwright-26th-annual-global-investment-conference [SID1234646088]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Anixa’s presentation will be available on-demand to registered attendees via the conference platform beginning Monday, September 9, 2024, at 7:00 AM Eastern Time. A webcast of the Company’s presentation can also be accessed at View Source and on the investor relations section of Company’s website at View Source

Management will be participating in one-on-one meetings with investors throughout the conference in New York City. To request a meeting, please contact [email protected].